{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T04:46:55.096783+00:00","published_at":"2026-10-17T04:46:55.096783+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:11867bg9bwnug","event_type":"GC_CHANGED","effective_at":"2026-04-20","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:david-zawitz","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d"],"summary":"David Zawitz executive of Verrica Pharmaceuticals Inc., effective 2026-04-20.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:idqxh9cpd0zb","event_type":"CEO_CHANGED","effective_at":"2026-04-20","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:jayson-rieger","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014"],"summary":"Jayson Rieger executive of Verrica Pharmaceuticals Inc., effective 2026-04-20.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cvzgfg8a2jau","event_type":"CFO_CHANGED","effective_at":"2026-04-20","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:john-j-kirby","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598"],"summary":"John J. Kirby executive of Verrica Pharmaceuticals Inc., effective 2026-04-20.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qda07m1p3tah6","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-20","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:noah-rosenberg","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c"],"summary":"Noah Rosenberg executive of Verrica Pharmaceuticals Inc., effective 2026-04-20.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1seovo9mr0v6l","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:charles-frantzreb","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Charles Frantzreb seat on Verrica Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vc6ufxavdbab","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:gavin-corcoran","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Gavin Corcoran seat on Verrica Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2ya3wp69czbl","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:jayson-rieger","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Jayson Rieger seat on Verrica Pharmaceuticals Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:a9xpd51i1i2wf","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:diem-nguyen","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Diem Nguyen seat on Verrica Pharmaceuticals Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:s9xfzi10z1irs","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:lawrence-eichenfield","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Lawrence Eichenfield seat on Verrica Pharmaceuticals Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1b1t5c3lkj8t7","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-chair","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Audit; Compensation · Chair committee of Verrica Pharmaceuticals Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16v8kle1vpng4y","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:diem-nguyen","alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Diem Nguyen member of Audit; Compensation · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xd9vfgb6l6n8","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of Verrica Pharmaceuticals Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u7x0ql2i6len","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:lawrence-eichenfield","alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Lawrence Eichenfield member of Audit; Compensation; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1a1cdab12hiejz","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:mark-prygocki","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Mark Prygocki seat on Verrica Pharmaceuticals Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sbfdfj1ixtsy7","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Audit · Chair; Compensation; Nominating and Governance committee of Verrica Pharmaceuticals Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ywckz88a374","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:mark-prygocki","alpha:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Mark Prygocki member of Audit · Chair; Compensation; Nominating and Governance, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jkfmihhkxodj","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:paul-b-manning","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Paul B. Manning seat on Verrica Pharmaceuticals Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6j2n8popayg","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:sean-stalfort","alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302"],"caused_claim_ids":["alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"],"summary":"Sean Stalfort seat on Verrica Pharmaceuticals Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-frantzreb","object_label":"Charles Frantzreb","object_source_name_forms":[],"value":"Charles Frantzreb: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-frantzreb","name":"Charles Frantzreb"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diem-nguyen","object_label":"Diem Nguyen","object_source_name_forms":[],"value":"Diem Nguyen: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diem-nguyen","name":"Diem Nguyen"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gavin-corcoran","object_label":"Gavin Corcoran","object_source_name_forms":[],"value":"Gavin Corcoran: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gavin-corcoran","name":"Gavin Corcoran"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jayson-rieger","object_label":"Jayson Rieger","object_source_name_forms":[],"value":"Jayson Rieger: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jayson-rieger","name":"Jayson Rieger"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lawrence-eichenfield","object_label":"Lawrence Eichenfield","object_source_name_forms":[],"value":"Lawrence Eichenfield: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lawrence-eichenfield","name":"Lawrence Eichenfield"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mark-prygocki","object_label":"Mark Prygocki","object_source_name_forms":[],"value":"Mark Prygocki: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mark-prygocki","name":"Mark Prygocki"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-b-manning","object_label":"Paul B. Manning","object_source_name_forms":[],"value":"Paul B. Manning: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-b-manning","name":"Paul B. Manning"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sean-stalfort","object_label":"Sean Stalfort","object_source_name_forms":[],"value":"Sean Stalfort: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sean-stalfort","name":"Sean Stalfort"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-zawitz","object_label":"David Zawitz","object_source_name_forms":[],"value":"David Zawitz: Chief Operating Officer, Chief Legal Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-zawitz","name":"David Zawitz"},"title":"Chief Operating Officer, Chief Legal Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.37821+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jayson-rieger","object_label":"Jayson Rieger","object_source_name_forms":[],"value":"Jayson Rieger: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jayson-rieger","name":"Jayson Rieger"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.440001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-j-kirby","object_label":"John J. Kirby","object_source_name_forms":[],"value":"John J. Kirby: interim Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-j-kirby","name":"John J. Kirby"},"title":"interim Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.912524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:noah-rosenberg","object_label":"Noah Rosenberg","object_source_name_forms":[],"value":"Noah Rosenberg: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:noah-rosenberg","name":"Noah Rosenberg"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.839874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.37821+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.440001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.912524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.839874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.841,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.6},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":12,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:55.096783+00:00","observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":"2026-10-17T04:46:55.096783+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/verrica-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}